A detailed history of Group One Trading, L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Group One Trading, L.P. holds 1,051,021 shares of TEVA stock, worth $23.2 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
1,051,021
Previous 1,052,077 0.1%
Holding current value
$23.2 Million
Previous $17.1 Million 10.78%
% of portfolio
0.79%
Previous 0.57%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $16,695 - $20,021
-1,056 Reduced 0.1%
1,051,021 $18.9 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $4.52 Million - $6.15 Million
353,543 Added 50.61%
1,052,077 $17.1 Million
Q1 2024

May 10, 2024

SELL
$10.67 - $14.43 $6.92 Million - $9.36 Million
-648,893 Reduced 48.16%
698,534 $9.86 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $5.84 Million - $7.65 Million
-719,620 Reduced 34.81%
1,347,427 $14.1 Million
Q3 2023

Nov 09, 2023

BUY
$7.48 - $10.7 $2.63 Million - $3.76 Million
351,673 Added 20.5%
2,067,047 $21.1 Million
Q2 2023

Aug 09, 2023

SELL
$7.2 - $9.47 $1.99 Million - $2.62 Million
-276,388 Reduced 13.88%
1,715,374 $12.9 Million
Q1 2023

May 12, 2023

SELL
$8.36 - $11.37 $11.7 Million - $16 Million
-1,403,864 Reduced 41.34%
1,991,762 $17.6 Million
Q4 2022

Feb 09, 2023

SELL
$7.95 - $9.48 $3.9 Million - $4.66 Million
-491,036 Reduced 12.63%
3,395,626 $31 Million
Q3 2022

Nov 09, 2022

SELL
$6.86 - $11.95 $4.29 Million - $7.47 Million
-624,986 Reduced 13.85%
3,886,662 $31.4 Million
Q2 2022

Aug 11, 2022

SELL
$7.38 - $10.4 $3.76 Million - $5.29 Million
-508,911 Reduced 10.14%
4,511,648 $33.9 Million
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $7.69 Million - $9.85 Million
-1,049,265 Reduced 17.29%
5,020,559 $47.1 Million
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $30.3 Million - $39.1 Million
3,833,905 Added 171.47%
6,069,824 $48.6 Million
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $2.2 Million - $2.67 Million
261,998 Added 13.27%
2,235,919 $21.8 Million
Q2 2021

Aug 10, 2021

BUY
$9.9 - $11.56 $6.27 Million - $7.32 Million
633,336 Added 47.24%
1,973,921 $19.5 Million
Q1 2021

May 12, 2021

SELL
$10.34 - $12.81 $16.8 Million - $20.8 Million
-1,624,499 Reduced 54.79%
1,340,585 $15.5 Million
Q4 2020

Feb 10, 2021

BUY
$8.61 - $11.04 $9.63 Million - $12.3 Million
1,118,209 Added 60.55%
2,965,084 $28.6 Million
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $3.56 Million - $5.28 Million
415,830 Added 29.06%
1,846,875 $16.6 Million
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $1.44 Million - $2.32 Million
-176,816 Reduced 11.0%
1,431,045 $17.6 Million
Q1 2020

May 13, 2020

BUY
$6.69 - $13.45 $7.2 Million - $14.5 Million
1,076,195 Added 202.42%
1,607,861 $14.4 Million
Q4 2019

Feb 10, 2020

BUY
$6.53 - $10.72 $3.47 Million - $5.7 Million
531,666 New
531,666 $5.21 Million
Q3 2019

Nov 12, 2019

SELL
$6.16 - $9.6 $2.06 Million - $3.2 Million
-333,604 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$8.12 - $15.72 $723,800 - $1.4 Million
89,138 Added 36.46%
333,604 $3.08 Million
Q1 2019

May 13, 2019

BUY
$15.58 - $20.01 $3.81 Million - $4.89 Million
244,466 New
244,466 $3.83 Million
Q1 2018

May 11, 2018

SELL
$16.68 - $22.07 $1.23 Million - $1.63 Million
-73,638 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $4.78 Million - $8.13 Million
-425,760 Reduced 85.25%
73,638 $1.4 Million
Q3 2017

Nov 15, 2017

SELL
$15.41 - $32.17 $1.24 Million - $2.59 Million
-80,577 Reduced 13.89%
499,398 $8.79 Million
Q2 2017

Aug 14, 2017

BUY
N/A
579,975
579,975 $19.3 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.